Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death - PubMed (original) (raw)

. 2009 Oct;15(10):1179-85.

doi: 10.1038/nm.2033. Epub 2009 Sep 27.

Affiliations

Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death

Stefania Gonfloni et al. Nat Med. 2009 Oct.

Abstract

Germ cells are sensitive to genotoxins, and ovarian failure and infertility are major side effects of chemotherapy in young patients with cancer. Here we describe the c-Abl-TAp63 pathway activated by chemotherapeutic DNA-damaging drugs in model human cell lines and in mouse oocytes and its role in cell death. In cell lines, upon cisplatin treatment, c-Abl phosphorylates TAp63 on specific tyrosine residues. Such modifications affect p63 stability and induce a p63-dependent activation of proapoptotic promoters. Similarly, in oocytes, cisplatin rapidly promotes TAp63 accumulation and eventually cell death. Treatment with the c-Abl kinase inhibitor imatinib counteracts these cisplatin-induced effects. Taken together, these data support a model in which signals initiated by DNA double-strand breaks are detected by c-Abl, which, through its kinase activity, modulates the p63 transcriptional output. Moreover, they suggest a new use for imatinib, aimed at preserving oocytes of the follicle reserve during chemotherapeutic treatments.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Trends Biochem Sci. 2003 Dec;28(12):663-70 - PubMed
    1. Cell. 1997 Feb 7;88(3):323-31 - PubMed
    1. Cell Cycle. 2006 Aug;5(16):1735-9 - PubMed
    1. Nat Cell Biol. 2005 Mar;7(3):278-85 - PubMed
    1. Mol Cell. 2004 Jun 4;14(5):625-36 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources